Cargando…
Reactive Oxygen Species, Metabolic Plasticity, and Drug Resistance in Cancer
The metabolic abnormality observed in tumors is characterized by the dependence of cancer cells on glycolysis for their energy requirements. Cancer cells also exhibit a high level of reactive oxygen species (ROS), largely due to the alteration of cellular bioenergetics. A highly coordinated interpla...
Autores principales: | Bhardwaj, Vikas, He, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279373/ https://www.ncbi.nlm.nih.gov/pubmed/32408513 http://dx.doi.org/10.3390/ijms21103412 |
Ejemplares similares
-
Reactive oxygen species in periodontitis
por: Dahiya, Parveen, et al.
Publicado: (2013) -
Reactive Oxygen Species: Physiological and Physiopathological Effects on Synaptic Plasticity
por: Beckhauser, Thiago Fernando, et al.
Publicado: (2016) -
Metabolic plasticity imparts erlotinib-resistance in pancreatic cancer by upregulating glucose-6-phosphate dehydrogenase
por: Sharma, Neha, et al.
Publicado: (2020) -
Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
por: Wang, Hai, et al.
Publicado: (2018) -
Mitochondrial reactive oxygen species and cancer
por: Sullivan, Lucas B, et al.
Publicado: (2014)